Mountain Pacific Investment Advisers »

Monopar Therapeutics shares owned by Mountain Pacific Investment Advisers

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Mountain Pacific Investment Advisers from 13F filings

Historical chart of Mountain Pacific Investment Advisers investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Mountain Pacific Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Mountain Pacific Investment Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $398k 6.1k 65.30

More positions owned by Mountain Pacific Investment Advisers

Amphenol Corp Cl A (APH)
Ametek (AME)
Danaher Corporation (DHR)
Thermo Fisher Scientific (TMO)
IDEX Corporation (IEX)
Arthur J. Gallagher & Co. (AJG)
Roper Industries (ROP)
Xylem (XYL)
Fiserv (FI)
Aptar (ATR)
Donaldson Company (DCI)
Vertiv Holdings Com Cl A (VRT)
Verisk Analytics (VRSK)
Gra (GGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)

View all positions for Mountain Pacific Investment Advisers

Top funds holding Monopar Therapeutics

Henderson Group
Adage Capital Partners GP
RA Capital Management
Vanguard Group
Wellington Management Company
BlackRock
Deerfield Management Company
Saturn V Capital Management
TCG Crossover Management
ADAR1 Capital Management
Vivo Capital
Geode Capital Management
Affinity Asset Advisors
State Street Corporation
Driehaus Capital Management

View all funds holding Monopar Therapeutics